Multidrug-Resistant Salmonella enterica Serotype Typhi, Gulf of Guinea Region, Africa - Volume 21, Number 4—April 2015 - Emerging Infectious Disease journal - CDC
Volume 21, Number 4—April 2015
Multidrug-Resistant Salmonella enterica Serotype Typhi, Gulf of Guinea Region, Africa
Typhoid fever, which is caused by Salmonella enterica serotype Typhi, is endemic to the developing world; there were an estimated 26.7 million cases in 2010 (1). The incidence of typhoid fever in sub-Saharan Africa was an estimated 725 cases/100,000 persons in 2010, despite a lack of incidence studies conducted in West and central Africa (1). Antimicrobial susceptibility data are also scarce for this part of Africa. This issue is problematic because treatment with appropriate antimicrobial drugs is essential for recovery in the context of the global emergence of multidrug resistance.
In the Indian subcontinent and Southeast Asia, the multidrug-resistant (MDR) Salmonella Typhi H58 clone, which was named after its haplotype (a combination of defined chromosomal single-nucleotide polymorphisms [SNPs]) (2,3), has spread rapidly and become endemic and predominant. During the 1990s, this clone acquired a large conjugative incHI1 pST6 plasmid encoding resistance to ampicillin, chloramphenicol, and co-trimoxazole (4,5); also in the 1990s, this MDR clone became resistant to quinolones and showed decreased susceptibility to ciprofloxacin because of point mutations in the chromosomal gyrA gene (2). The H58 clone has also spread to eastern Africa, where it has been the most prevalent haplotype (87%) in Kenya since the early 2000s (6).
During 1997–2011, high incidence of MDR Salmonella Typhi was reported in some countries near the Gulf of Guinea in Africa, including Nigeria (7), Ghana (8,9), Togo (10), and the Democratic Republic of the Congo (11). During 1999–2003, a British surveillance system reported a prevalence of 19% (49/421) for MDR Salmonella Typhi isolates among imported cases of typhoid fever acquired in Africa, particularly in Ghana (12). However, nothing is known about the genotypes of these isolates, including whether they belong to the spreading MDR H58 clone.
We report data for the occurrence, genotypes, and characterization of the resistance mechanisms of MDR Salmonella Typhi isolates. These isolates were obtained from the French National Reference Center for Salmonella (FNRC-Salm), Institut Pasteur (Paris, France), and Centre Pasteur du Cameroun (Yaoundé, Cameroon).
We thank all the corresponding laboratories of the FNRC-Salm network for participating in this study.
This study was supported by the Institut Pasteur, the Réseau International des Instituts Pasteur, the Institut de Veille Sanitaire, and the French Government Investissement d'Avenir Program (Integrative Biology of Emerging Infectious Diseases, Laboratory of Excellence, grant ANR-10-LABX-62-IBEID).
- Buckle GC, Walker CL, Black RE. Typhoid fever and paratyphoid fever: systematic review to estimate global morbidity and mortality for 2010. J Glob Health. 2012;2:010401. DOIPubMed
- Roumagnac P, Weill FX, Dolecek C, Baker S, Brisse S, Chinh NT, Evolutionary history of Salmonella Typhi. Science. 2006;314:1301–4.DOIPubMed
- Holt KE, Parkhill J, Mazzoni CJ, Roumagnac P, Weill FX, Goodhead I, High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi. Nat Genet. 2008;40:987–93. DOIPubMed
- Phan MD, Kidgell C, Nair S, Holt KE, Turner AK, Hinds J, Variation in Salmonella enterica serovar Typhi IncHI1 plasmids during the global spread of resistant typhoid fever. Antimicrob Agents Chemother. 2009;53:716–27. DOIPubMed
- Holt KE, Phan MD, Baker S, Duy PT, Nga TV, Nair S, Emergence of a globally dominant IncHI1 plasmid type associated with multiple drug resistant typhoid. PLoS Negl Trop Dis. 2011;5:e1245. DOIPubMed
- Kariuki S, Revathi G, Kiiru J, Mengo DM, Mwituria J, Muyodi J, Typhoid in Kenya is associated with a dominant multidrug-resistant Salmonella enterica serovar Typhi haplotype that is also widespread in Southeast Asia. J Clin Microbiol. 2010;48:2171–6. DOIPubMed
- Akinyemi KO, Coker AO. Trends of antibiotic resistance in Salmonella enterica serovar typhi isolated from hospitalized patients from 1997 to 2004 in Lagos, Nigeria. Indian J Med Microbiol. 2007;25:436–7. DOIPubMed
- Mills-Robertson F, Addy ME, Mensah P, Crupper SS. Molecular characterization of antibiotic resistance in clinical Salmonella typhi isolated in Ghana.FEMS Microbiol Lett. 2002;215:249–53. DOIPubMed
- Gross U, Amuzu SK, de Ciman R, Kassimova I, Gross L, Rabsch W, Bacteremia and antimicrobial drug resistance over time, Ghana. Emerg Infect Dis.2011;17:1879–82. DOIPubMed
- Dagnra AY, Akolly K, Gbadoe A, Aho K, David M. Emergence of multidrug resistant Salmonella strains in Lome (Togo) [in French]. Med Mal Infect.2007;37:266–9. DOIPubMed
- Lunguya O, Lejon V, Phoba MF, Bertrand S, Vanhoof R, Verhaegen J, . Salmonella Typhi in the Democratic Republic of the Congo: fluoroquinolone decreased susceptibility on the rise. EPLoS Negl Trop Dis. 2012; 6:e1921. Doe: . Pub 2012 Nov 5.DOI
- Cooke FJ, Day M, Wain J, Ward LR, Threlfall EJ. Cases of typhoid fever imported to England, Scotland and Wales (2000–2003). Trans R Soc Trop Med Hyg. 2007;101:398–404. DOIPubMed
- Loury P, Tillaut H, Faisant M, Paillereau N, Marquis M, Mari C, Cluster of typhoid fever cases in Ille-et-Vilaine (France), April 2009 [in French]. Bull Epidémiol Hebd. 2010;44:446–8.
- Le Hello S, Harrois D, Bouchrif B, Sontag L, Elhani D, Guibert V, Highly drug-resistant Salmonella enterica serotype Kentucky ST198-X1: a microbiological study. Lancet Infect Dis. 2013;13:672–9. DOIPubMed
- Fabre L, Le Hello S, Roux C, Issenhuth-Jeanjean S, Weill FX. CRISPR is an optimal target for the design of specific PCR assays for Salmonella entericaserotypes Typhi and Paratyphi A. PLoS Negl Trop Dis. 2014;8:e2671 . DOIPubMed
Suggested citation for this article: Baltazar M, Ngandjio A, Holt KE, Lepillet E, Pardos de la Gandara M, Collard J-M, et al. Multidrug-resistant Salmonella enterica serotype Typhi, Gulf of Guinea Region, Africa. Emerg Infect Dis. 2015 Apr [date cited]. http://dx.doi.org/10.3201/eid2104.141355
1These authors contributed equally to this article.
2Current affiliation: University of Limoges, Limoges, France.
3Current affiliation: Rockefeller University, New York, New York, USA.
4Current affiliation: Institute Pasteur de Dakar, Dakar, Senegal.
No hay comentarios:
Publicar un comentario